Patent ID: 11952376
Assignee: PLIANT THERAPEUTICS, INC.
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 139:
140. The compound of claim 138, wherein the compound is of formula (II-B-2) or formula (II-B-3):, or a pharmaceutically acceptable salt, stereoisomer, or tautomer thereof,
wherein:
R3 is pyrimidinyl, quinazolin-5-yl, quinazolin-6-yl, quinazolin-7-yl, or quinazolin-8-yl:
wherein the pyrimidinyl is optionally substituted by 1, 2, or 3 independently selected R3e substituents; and
wherein the quinazolin-5-yl, quinazolin-6-yl, quinazolin-7-yl, or quinazolin-8-yl is optionally substituted by 1, 2, 3, or 4 independently selected R3e substituents.